Results 21 to 30 of about 779,573 (302)

Myofascial trigger points in migraine and tension-type headache

The Journal of Headache and Pain, 2018
Background A myofascial trigger point is defined as a hyperirritable spot in skeletal muscle that is associated with a hypersensitive palpable nodule in a taut band.
Thien Phu Do, Gerda Ferja Heldarskard, Lærke Tørring Kolding, Jeppe Hvedstrup, Henrik Winther Schytz   +4 more
doaj   +1 more source

Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study

BMC Neurology, 2021
Background We aim to describe and compare patients and general practitioners’ opinions about the different variables related to acute and preventive treatment for migraine. Patients and methods An observational descriptive study was performed.
Javier Trigo-López, Ángel Luis Guerrero-Peral, Álvaro Sierra, Enrique Martínez-Pías, María Gutiérrez-Sánchez, Elizabeth Huzzey, David García-Azorín   +6 more
doaj   +1 more source

The effect of placebo and neurophysiological involvements [PDF]

, 2004
Placebo and placebo effect are important issues related to the drug therapy for clinical and scientific meanings. The rates of placebo may get as many as 50% for analgesic drugs in headache. The high answer to placebo brings questions on pathophysiology
Galli, Federica, Guidetti, Vincenzo, Riccio, B.   +2 more
core   +1 more source

Migraine, headache, and mortality in women: a cohort study [PDF]

, 2020
Background: Migraine carries a high global burden, disproportionately affects women, and has been implicated as a risk factor for cardiovascular disease. Migraine with aura has been consistently associated with increased risk of cardiovascular mortality.
Buring, Julie Elizabeth, Kurth, Tobias, Rist, Pamela Marie, Rohmann, Jessica Lee   +3 more
core   +1 more source

P003. NSAIDs for symptomatic treatment of headache [PDF]

, 2015
Background and aims Clinical observations suggest that the use of non-steroidal anti-inflammatory drugs (NSAIDs) for symptomatic treatment of headache is not in line with recommendations by international guidelines [1].
Affaitati, Giannapia, Cipollone, Francesco, Costantini, Raffaele, Giamberardino, Maria Adele, Lapenna, Domenico, Lopopolo, Mariangela, Martelletti, Paolo, Massimini, Francesca, Tana, Claudio   +8 more
core   +1 more source

Metacognition and headache: which Is the role in childhood and adolescence? [PDF]

, 2017
Headache, in particular migraine, is one of the most frequent neurological symptoms in children and adolescents and it affects about 60% of children and adolescents all over the world.
Calderoni, D, Cerutti, R, Faedda, N, Guidetti, V., Natalucci, G, Verdecchia, P   +5 more
core   +6 more sources

The prevalence of primary headache disorders in Ethiopia [PDF]

, 2016
BACKGROUND: Knowledge of the epidemiology of primary headache disorders in sub-Saharan Africa (SSA) remains very limited. We performed a population-based survey in rural and urban areas of Ethiopia, using methods similar to those of an earlier study in ...
Steiner, TJ, Tekle-Haimanot, R, Thomas, H, Worku, DK, Zebenigus, M   +4 more
core   +2 more sources

Migraine and cluster headache show impaired neurosteroids patterns [PDF]

, 2019
Background: Perturbation of neuronal excitability contributes to migraine. Neurosteroids modulate the activity of γ-aminobutyric acid A and N-methyl-d-aspartate receptors, and might be involved in the pathogenesis of migraine.
Capi, M., Cicione, C., De Marco, C. M., Di Menna, L., Guglielmetti, M., Koverech, A., Lionetto, L., Maestri, M., Martelletti, P., Negro, A., Nicoletti, F., Passariello, F., Sabbatini, E., Simmaco, M.   +13 more
core   +1 more source

Medication-overuse headache—a review of different treatment strategies

Frontiers in Pain Research, 2023
Medication-overuse headache (MOH) can develop from primary headaches. MOH is usually the result of overuse of symptomatic medications. It is a noteworthy personal and societal burden.
Abouch Krymchantowski, Carla Jevoux, Ana Gabriela Krymchantowski, Luiza Barbosa Ramos, Jackeline S. S. Barbosa, Raimundo Pereira Silva-Neto   +5 more
doaj   +1 more source

Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report [PDF]

, 2015
Chronic cluster headache (CCH) is a rare and extremely disabling headache syndrome with a recent clinical systematization of its clinical frame from the European Headache Federation [1]. We present a case of a young man affected by drug-resistant chronic
Arcioni, Roberto, D'Alonzo, Lidia, Martelletti, Paolo, Mercieri, Marco, Negro, Andrea, Silvestri, Barbara, Tigano, Sara   +6 more
core   +1 more source